Sign up to save your podcasts
Or
Share ACCEL Lite: Featured ACCEL Interview With Spencer King and David Fitchett
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Featured ACCEL Interview With Spencer King and David Fitchett
In this interview, Spencer King and David Fitchett discuss the relationship between hypoglycemia outcomes and empagliflozin treatment in the EMPA-REG OUTOME trial (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients).
View all episodes
By American College of Cardiology
3.7
5353 ratings
In this interview, Spencer King and David Fitchett discuss the relationship between hypoglycemia outcomes and empagliflozin treatment in the EMPA-REG OUTOME trial (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients).
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
325 Listeners
JACC This Week
161 Listeners
This Week in Cardiology
865 Listeners
JAMA Clinical Reviews
496 Listeners
Mayo Clinic Talks
281 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
JAMA Medical News
90 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
185 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners
Mayo Clinic Cardiovascular CME
37 Listeners